Research Gateway IRB Transition

regi10

 

UCSF is replacing the iRIS IRB submission system with a new system called Research Gateway IRB. This page explains why the change is happening, key transition dates, how to prepare, and what to expect during the transition. 

This page will be continually updated with additional guidance—especially the FAQs—so please revisit often!

 

Research Gateway IRB Transition

📤

Wed, April 1

New Full Committee Studies

Submit in iRIS by 4/1 for best chance of approval before go live.

❄️

June 13-30

Submission Freeze

No submissions allowed in iRIS or Research Gateway IRB.

🚀

Wed, July 1

Go Live

Research Gateway IRB launches for all submissions.

Top

Key Information

ChangeImpact/Details
What is changing?
  • The iRIS IRB submission system will be replaced by Research Gateway IRB.
  • Records of approved IRB studies—including key study information and the latest approved study documents – will appear in Research Gateway IRB.
Who is affected: 
  • Principal Investigators (PIs)
  • Study coordinators and research staff
  • Anyone submitting materials to the UCSF IRB or accessing research records in iRIS
Key transition dates: 
  • Submission Freeze: June 13-30, 2026
  • Go-Live Date: Wed, July 1, 2026
  • Important: No IRB submissions can be made during the submission freeze period while study data is migrated to the new system.

Top

Timeline

MilestoneDescriptionDate
Submission FreezeNo IRB submissions accepted during migration preparationJune 13 - June 30, 2026
Research Gateway IRB Go-LiveNew system opens for submissionsWed, July 1, 2026
iRIS SunsetRead-only access expected to end - archived data from iRIS will be accessible in another system.Mid-2027 (tentative)

Top

Submission Freeze, June 13-30th, 2026

No submissions will be accepted in iRIS or Research Gateway IRB starting at 12:00AM on June 13, 2026. This includes: 

Top

How to Prepare

CategoryKey Actions & Requirements
Manage Approved iRIS Studies

❌ Remove research personnel who are no longer part of the study according to IRB guidance on personnel changes. Some approved iRIS studies may fail to migrate to Research Gateway IRB if they include Key Study Personnel (KSP) who are no longer affiliated with UCSF. See the IRB quick guide for step-by-step instructionsexternal site (opens in a new window) on updating study personnel.

Manage Submissions Undergoing IRB Review

To increase the likelihood of IRB approval before the system transition, please: 

Note: Submissions not approved before the transition must be resubmitted in Research Gateway IRB. 

Consider Timing for Upcoming Submissions

Submission TypeGuidance/Next Steps
Any submission that does not fit into one of the below categories

If possible, wait until after Wed, July 1, 2026.

If your submission does not require approval before the transition, consider delaying it until the new system launches. This includes:

Tip: Submissions made after July 1, 2026, may help avoid the need to recreate submissions in the new system.

If approval is needed before the transition: 

If your study requires approval before the system change, submit as early as possible. Please note:

  • 📩 Respond promptly to IRB stipulations during the review process.
  • ⏳  Expect longer processing times during the transition period.
  • ⚠️ Approval is not guaranteed for submissions made close to the submission freeze.
New Full Committee StudiesNew studies that require Full Committee Review are no longer being accepted in iRIS. Submit new Full Committee Studies in Research Gateway IRB beginning Wed, July 1, 2026. Training and materials will be available in June to get you ready for a July 1st submission.
Continuing Review🔄 Use this chart to determine when and how to submit your Continuing Review: IRB Continuing Review Schedule April-September 2026.
Reportable New Information: Adverse events, protocol violations & incidents, and reportable safety information🛑 Do not submit reportable new information during the submission freeze unless it may affect whether the study can continue. In such cases, notify us via the Ask Andy form. If the event does not impact study continuation, wait to submit it in Research Gateway IRB.
Reliance

If you plan to add external sites:

🤝 Request a Reliance team consultation early, as the process will change with the new system. 

If you wish to rely on an external academic medical center IRB, or any IRB other than WCG, Advarra, Jaeb, NCI CIRB, or Fresno Community Health System (formerly Community Medical Centers in Fresno):

  • We strongly discourage submitting any new iRIS studies that rely on an external IRB other than WCG, Advarra, Jaeb, NCI CIRB, or Fresno Community Health System (formerly Community Medical Centers in Fresno). Due to the upcoming system transition and data migration, it is unlikely that these submissions can be fully processed before the transition occurs.
  • Please wait to submit in Research Gateway IRB on July 1.

Studies relying on WCG, Advarra, Jaeb, NCI CIRB, or Fresno Community Health System (formerly Community Medical Centers in Fresno) will follow the standard submission freeze timeframe.  

Top

Training and Learning the New System

Training schedules and materials are available on the Research Gateway IRB training page.

Top

What to Expect at Go-Live

What should you do after Wed, July 1, 2026? 

Your next steps depend on your study's status in iRIS. Choose your situation: 

If this applies to youGo to section
My study was already approved in IRISApproved studies
My submission was under review in iRIS but not approved before July 1, 2026Resubmitting after the transition
I am submitting a new study, modification, personnel change, continuing review, or reportable new information after July 1, 2026.New submissions after go-live
Study StatusGuidanceWhat you need to do
Approved Studies 

If your study was approved in iRIS before the transition:

  • A shell record will appear in Research Gateway IRB with key study information and the latest approved documents.
  • iRIS study numbers will be preserved.
  • iRIS will remain available in read-only mode
  • Prior submission history and documentation will be accessible through an archived library linked to each study record.
👉 Review your study in Research Gateway IRB to confirm everything is accurately migrated.
Resubmitting After the Transition 

If your study was under review in iRIS but not approved before July 1, 2026:

  • Your submission will not continue in iRIS.
  • You will need submit your study again in Research Gateway IRB
  • Tools will be available to help transfer your information
👉 Resubmit your study in the new system.
New Submissions After Go-Live

Beginning Wed, July 1, 2026

All IRB submissions will be processed in Research Gateway IRB, including:

  • New studies, Modifications, Personnel changes, Continuing reviews, and Reportable New Information (adverse events, protocol violations, incidents, and other safety reports)

Required for New Studies, Modifications, and Personnel Changes

Study teams must:

  • 📎 Attach a UCSF Investigator Protocol (Word Document) to the study record in Research Gateway IRB.
  • 📅 Investigator Protocol templates will be released in June, so you can start preparing your submission before go-live.

👉 Use Research Gateway IRB for all submissions.

👉 Prepare UCSF Investigator protocol using upcoming templates before go-live.

📣 Three Big Changes to Expect in Research Gateway IRB

ChangeDetailed Guidance
Study SmartForm + Investigator Protocol

The current IRB Application in iRIS is a highly programmed SmartForm that uses show/hide logic. In the new Research Gateway IRB system, we are moving to a more document-driven approach. You will still complete an IRB Study SmartForm, but it will be significantly shorter.

Most study information will instead be captured in a Word document called the Investigator Protocol, which you will complete using a template and upload in the SmartForm. This approach makes it easier for study teams to collaborate and allows you to view all IRB questions at once, rather than navigating through them step by step.

Detailed mapping documents will be available to show how current iRIS questions align with the new Investigator Protocol template. Templates will be shared in June. Note: While some questions have been reworded or combined, most will feel familiar. And you’ll be pleased to hear that several questions have been removed entirely.

Approved studies being migrated will receive a partially pre-populated Investigator Protocol based on information from their most recent iRIS application.

REgii2
Separate Submission to GESCR via the Safety Module

Another change involves the Human Gamete, Embryo, and Stem Cell Research (GESCR) submission process. In iRIS, the GESCR application is embedded within the IRB application. However, not all GESCR studies require IRB review, which means some study teams currently answer IRB questions that do not apply to their research.

In the Research Gateway IRB system, GESCR and IRB submissions will be separated. GESCR studies will be submitted through the Safety Module and can be linked to a corresponding IRB submission when review by both groups is required.

System Roles and Notification Recipients

Some system roles and notification recipients are changing in the Research Gateway IRB system.

The PI Proxy Role

The PI Proxy is a new system role that allows a designated individual to submit an IRB submission on behalf of the PI. Key details regarding this role include:

  • Only the PI of a study can assign a PI Proxy.
  • Multiple PI Proxies can be assigned to a single study.
  • The PI Proxy must be a member of the study team and listed in the IRB Study SmartForm.
  • The PI assigns a PI Proxy from the study's main workspace. A modification is only required if the individual also needs to be added to the study team.
  • The PI Proxy role applies only within the system and does not grant authority to act for the PI in other contexts.

The Primary Contact Role

The Primary Contact is another system role in Research Gateway IRB. Unlike iRIS, where multiple Study Contacts can receive notifications, Research Gateway IRB allows only one Primary Contact per study. This individual will be copied on all system notifications.

Here’s a table summarizing these changes: 

What's ChangingCurrent: iRISNew: Research Gateway IRB
PI Proxy roleN/ASystem role that allows a designated study team member to submit on the PI’s behalf. Only the PI can assign a PI Proxy. Multiple PI Proxies are allowed.
ContactsMultiple Study Contacts allowedOnly one Primary Contact per study
Who can submitStudy team members can submit some types of IRB submissions, while the PI must submit othersOnly the PI or PI Proxy can submit to the IRB – the only exception is post-approval event reports, which are called Reportable New Information (RNI) reports in the Research Gateway IRB
Notification recipientsPI + Study ContactsPI, PI Proxies, and Primary Contact

🔁 What information will be migrated from iRIS to Research Gateway? 

Not all information will move to the new system. Review the lists below to understand what will be transferred and what may require your attention.

What will migrate?Guidance
Approved IRB Studies

Most currently approved studies will have a “shell record” created in Research Gateway IRB. This means information from your iRIS study record will be migrated to pre-populate most – but not all – of the new Study SmartForm in Research Gateway IRB.

When you submit your first modification in Research Gateway IRB, you will need to review and validate this information, complete any missing fields, and upload a completed UCSF Investigator Protocol. Please see Key System Changes

Studies with the following statuses at the time of the submission freeze will be migrated:

  • Active - Closed to Accrual;
  • Active - Data Analysis Only
  • Active - Data Analysis Only - NoExpire
  • Active - Expedited
  • Active - Expedited - No Continuing Review
  • Active - Full Board
  • Active - Hold on Accrual
  • Active - No Subject Contact
  • Active - No Subject Contact - NoExpire
  • Active- Expedited C2A - NoExpire
  • Active- FollowUp C2A- NoExpire
  • CIRB Reviewed
  • Expedited GESCR/Expedited IRB
  • Expedited GESCR/Full IRB
  • Expedited GESCR/Other Non-UCSF IRB
  • Full GESCR/Full IRB
  • HUD Study
  • Other Non-UCSF IRB Reviewed
  • Private IRB Reviewed
  • sIRB Active Expedited
  • sIRB Active Expedited NoExpire
  • sIRB Active Full Board
  • sIRB Active No Subject Contact
  • sIRB Active No Subject Contact NoExpire
  • Suspended
  • UC BRAID Relying on Other UC
  • UC MOU Relying
     
Post-approval event reports (limited)

Only reports with any of the following outcomes will be migrated: 

  • Serious Noncompliance, Continuing Noncompliance, and/or Unanticipated Problem
  • Suspended

Note: In Research Gateway IRB, these are called Reportable New Information (RNI).

Basic regulatory informationLimited regulatory data needed to support ongoing IRB oversight will be migrated, such as expiration dates (if applicable) and select approval information.
Current approved/acknowledged consent forms and other study documentsDocuments that are approved/acknowledged at the time of the submission freeze will be migrated (see migration table)
Approved GESCR studies

In Research Gateway, GESCR submissions will be separate from IRB submissions and will be managed within the Safety Module. Depending on whether your study involves human research, it will be migrated to both the IRB and Safety modules, or to Safety only.

A “shell record” will be created for each GESCR study in the Safety Module. Because only limited GESCR information can be migrated, you will need to review and validate the migrated data and complete any missing fields when prompted.
 

What will not migrate?Guidance
This information will be accessible in iRIS until it is taken offline in 2027. Most information will also be accessible in SharePoint via a link in Research Gateway IRB (exceptions noted).
Exempt studies

Your non-closed, exempt study is still considered “active” even though it has not been migrated to the Research Gateway IRB. You can continue to conduct the research. If you need to make changes to the study, first consider whether the changes are minor or significant.

  • Minor Changes: You can make minor changes to the study without notifying the IRB. This only applies to exempt studies.

  • Significant Changes: You will need to submit the research as a new study in Research Gateway IRB. The IRB will review the study and determine whether it still qualifies for exemption.

Closed or withdrawn studies 
Previously approved modifications and continuing reviews 
Currently unapproved consent forms and other study documentsIncludes drafts or prior versions of consent forms and other study documents that are not currently approved at the time of the submission freeze.
Most post-approval event reports. See exceptions in the list above. 
IRB outcome lettersIncludes approval letter and other determination letters. 
Draft or unapproved submissionsIncludes drafts and submitted (but not approved) submissions, including submissions returned for changes. These will only be available in iRIS until it is retired in 2027.
Non-Human Subject Research (NHSR) determinationsThese will only be available in iRIS until it is retired in 2027.
IRB meeting materialsIncludes meeting agendas, minutes, and related materials.

Migration Summary Table 

IRB and GESCR Submissions

Type of SubmissionMigrated to Research Gateway IRBAccessible via iRIS or SharePoint (via link in Research Gateway IRB)Accessible via iRIS Only (No Access After iRIS is Retired in 2027)
Approved IRB studies (see specific statuses above) 

X (shell record)

 

 

Post-approval event reports (depends on outcome - see specific statuses above)

X (some)

X (some)

 

Exempt studies

 

X

 

Closed or withdrawn studies

 

X

 

Previously approved modifications and continuing reviews

 

X

 

Draft submissions or submitted, unapproved submissions 

 

 

X

Non-Human Subject Research (NHSR) determinations

 

 

X

Approved GESCR studies

X (shell record)

 

 

Documents

Document TypeResearch
Gateway IRB
Accessible via iRIS or SharePoint
(via link in Research Gateway IRB)
Currently approved/acknowledged study documents

X

 

Currently approved stamped consent form
and editable version of the approved
consent form

X

 

Historical consent forms and other study
documents 

 

X

Approval letters and other outcome letters

 

X

IRB meeting materials (e.g., minutes,
agendas) 

 

X

Top

OnCore Integration

For detailed OnCore workflow and system changes, see the Office of Clinical Trial Administration (OCTA) guidance at OnCore Changes with Research Gateway IRB - 2026.

Top

Frequently Asked Questions

This FAQ provides guidance on what to expect, including system integrations, workflow changes, and the management of existing studies. This is a living document that will be updated as new information becomes available. For specific questions raised during the March 25th Town Hall, please refer to our separate supplemental Q&A document.

System Transition

1. Why is iRIS being replaced?
  1. Reliability and sustainability: The iRIS system experiences frequent timeouts that delay submissions and frustrate users. The system can no longer be upgraded, and UCSF needs a reliable IRB submission platform for the long term.
  2. Part of a broader research systems initiative: The new system is part of a larger initiative to consolidate research compliance tools into a single shared platform. Research Gateway currently supports Conflict of Interest and will support IRB, Grants & Agreements, and Export Control over time.
2. Why was Research Gateway IRB selected?

A cross-campus committee evaluated multiple vendors and selected Huron Research Suite for its:

  • Functionality
  • Compliance support
  • System reliability
  • Strong reputation among research institutions

The platform is widely used by research-intensive universities, commercial IRB partners, and several UC campuses.

3. Will my existing studies move to the new system?

Yes. Currently approved studies will appear as shell records, which means that key information about the study and the latest approved documents will be transferred to Research Gateway IRB. This is called study migration.

4. Will I still be able to access iRIS?

Yes. iRIS will remain available in read-only mode until approximately mid-2027. After iRIS is decommissioned completely, study records from iRIS will be accessible in an archive (details forthcoming).

5. What happens if my submission is not approved before the transition?

It will need to be resubmitted in Research Gateway IRB.

Submissions & Workflow

6. Will processing times change?

There may be longer processing times during the transition period.

7. Will the IRB review process change?

The regulatory review process itself will remain the same, although submission workflows may differ.

8. Will the Gamete, Embryo and Stem Cell Research (GESCR) process change? 

Yes. The GESCR review process will become independent from IRB submission workflows in the Research Gateway Safety module. Trainings and job aids will be provided in June. 

System Integration 

9. Will Research Gateway IRB interact with OnCore?

Top

Contact

If you have questions about this transition, please contact: 

Research Gateway Project Team at [email protected].

Top

Information Sessions

SessionsDate/TimeInvite/Materials
Past
Research Gateway Town Hall: IRB System ReplacementWed, March 25, 11:00–12:00

If you work at an UCSF Affiliated Institution, you can request access to these materials by emailing Kate Nolan

Clinical Trials Operations (CTO) Research ForumThurs, April 9, 11:00–12:00

Top

Previous Communications

Earlier communications about this transition include:

OfficeCommunication
Academic Research Services (ARS)
Office of Research (OoR)
  • November–December 2024 Research Resource article 
Clinical Trials Operations (CTO)

Top

Last updated: